NASDAQ
Cytek Biosciences, Inc. (CTKB) has a current ratio of 5.04x as of Monday, May 25, 2026. This represents a 42.59% decrease compared to its 12-month average of 8.78x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.